+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Stem Cells Market - Global Forecast to 2030- Product Image
Stem Cells Market - Global Forecast to 2030- Product Image
New

Stem Cells Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082652
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Stem Cells Market grew from USD 15.05 billion in 2024 to USD 16.72 billion in 2025. It is expected to continue growing at a CAGR of 10.91%, reaching USD 28.02 billion by 2030.

The stem cell market stands at a pivotal juncture, where groundbreaking research intersects with commercial opportunities to redefine healthcare and life sciences. As advances in cell biology accelerate, stakeholders across academia, biotechnology, and clinical practice are harnessing the unique properties of stem cells to address unmet medical needs, drive drug discovery, and pioneer regenerative therapies. This introduction frames the strategic significance of stem cell technologies by outlining their current role in oncology, pharmacology, and tissue engineering, while highlighting emerging regulatory landscapes and evolving investor sentiment. By understanding the foundational drivers-scientific breakthroughs, ethical considerations, and policy frameworks-readers will be equipped to appreciate how ongoing innovations are reshaping the trajectory of patient care and research paradigms.

Transformative Shifts Redefining the Stem Cell Landscape

In recent years, several transformative forces have converged to redefine the stem cell ecosystem. Breakthroughs in induced pluripotent stem cell reprogramming and advances in CRISPR-based gene editing have unlocked new avenues for personalized medicine. Concurrently, improvements in three-dimensional cultivation techniques and scalable bioreactor systems have elevated manufacturing capacity, paving the way for more consistent, cost-efficient cell therapy production. On the regulatory front, streamlined approval pathways in key markets are accelerating clinical translation, while public-private partnerships and consortium models are fostering collaborative innovation. Together, these shifts are dismantling traditional silos between discovery and commercialization, ushering in a new era where cross-disciplinary integration and digital tools optimize every stage of development.

Cumulative Impact of United States Tariffs in 2025

The introduction of new tariff measures in the United States during 2025 has exerted notable pressure on the cost structure of imported cell culture reagents, bioprocessing equipment, and specialized consumables essential to stem cell workflows. As import duties rise, organizations have been compelled to re-evaluate supplier contracts and logistics strategies to preserve margins. Some manufacturers are exploring vertical integration or forging partnerships with domestic producers to mitigate exposure to fluctuating tariff schedules. At the same time, research institutions are recalibrating budgets to accommodate higher overhead, accelerating efforts to qualify locally sourced raw materials. Although these protective measures aim to bolster domestic manufacturing, they also introduce supply-chain complexity, encouraging stakeholders to adopt more flexible procurement practices and diversify their sourcing footprints.

Key Segmentation Insights Shaping Stem Cell Innovations

Analyzing the market through its core segmentation dimensions reveals nuanced growth opportunities and challenges. When observing the landscape based on type, adult stem cells-including epithelial, hematopoietic, mesenchymal, neural, and skin lineages-continue to dominate translational research and therapeutic pipelines, while embryonic stem cells remain constrained by ethical considerations despite their pluripotent potential. Induced pluripotent stem cells, driven by both differentiation applications and reprogramming methods, are rapidly gaining prominence for disease modeling and autologous therapies. Perinatal sources, such as placental and umbilical cord blood cells, are garnering interest for their immunomodulatory properties and relative accessibility.

Shifting attention to application, cancer research benefits from stem cell-based tumorigenesis models and cell therapies in oncology, while drug development leverages pharmacodynamics assays, target identification platforms, and toxicology studies to streamline candidate selection. In regenerative medicine, cell therapy, organ transplantation scaffolds, and tissue-engineering constructs are converging to address complex repair needs, whereas fundamental research in cell biology, developmental biology, and gene editing continues to underpin innovation.

From a technology standpoint, refinements in cryopreservation-spanning slow-freezing methods and vitrification techniques-are extending cell viability and distribution reach. Cultivation advances, whether through bioreactors or three-dimensional cultures, are enhancing yield and functional consistency. Meanwhile, gene-editing tools, particularly CRISPR, TALENs, and zinc finger nucleases, are empowering precise genomic interventions with growing clinical ambitions.

Considering source, allogeneic cell lines derived from cord blood and placenta offer off-the-shelf scalability, whereas autologous therapies drawn from bone marrow and peripheral blood provide personalized safety profiles. Finally, end-user segmentation underscores the diversity of demand: academic institutes with dedicated stem cell departments, biotechnology companies focused on biomanufacturing and therapeutic development, contract research organizations executing clinical and preclinical studies, and hospitals and clinics operating specialized stem cell therapy and transplant units all contribute distinct perspectives and purchasing behaviors.

Key Regional Dynamics Driving Market Development

Regional landscapes exhibit distinct drivers and adoption patterns that influence overall market dynamics. In the Americas, robust funding ecosystems, anchored by both public grants and venture capital, empower start-ups and established players alike to scale manufacturing and clinical trials rapidly. The United States leads with progressive regulatory guidance and comprehensive reimbursement frameworks, while Canada’s emphasis on collaborative research networks bolsters translational initiatives.

In Europe, Middle East & Africa, regulatory harmonization within the European Union facilitates cross-border collaborations and streamlines clinical approvals, particularly in Germany, the Netherlands, and the United Kingdom. Meanwhile, emerging hubs in the Middle East and Africa are capitalizing on strategic investments to build infrastructure for stem cell research and therapy, laying the groundwork for future expansion.

Asia-Pacific markets demonstrate aggressive innovation trajectories. Japan’s long-standing support for regenerative medicine has yielded pioneering approvals and a mature manufacturing sector. China’s rapidly evolving regulatory regime and substantial domestic demand underpin large-scale cell therapy ventures, while South Korea leverages its biotech manufacturing prowess to produce cost-effective solutions. Across the region, an emphasis on public health initiatives and diversified funding models is driving greater access and adoption of cutting-edge stem cell applications.

Leading Companies Steering Stem Cell Advancements

A diverse array of companies is at the forefront of stem cell development, each contributing unique capabilities to the ecosystem. Advanced Cell Technology, Inc. and its successors are renowned for pioneering pluripotent cell lines, whereas AlloSource, Inc. specializes in the tissue banking and allogeneic graft segments. Anterogen Co., Ltd. and Athersys Inc. are advancing clinical-stage pipelines in regenerative therapies, while Becton, Dickinson and Company provides essential instrumentation and consumables for cell processing.

Bioheart Inc. and Biorestorative Therapies Inc. maintain targeted portfolios in cardiovascular applications, complemented by BioTime, Inc.’s focus on pluripotent-derived constructs. BrainStorm Cell Therapeutics Inc. is developing neural cell therapies for neurodegenerative conditions, and Celgene Corporation continues to integrate stem cell technologies within its broader hematology franchise. Cellartis AB and CellGenix GmbH enhance research and clinical capabilities with specialized media and cytokine formulations, while Cellular Engineering Technologies Inc. offers advanced cell culture platforms.

Gamida Cell Ltd and GenScript Biotech Corporation leverage proprietary processes in hematopoietic and gene-edited cell products, and Gilead Sciences, Inc. explores stem cell approaches for viral and inflammatory diseases. Holostem Terapie Avanzate Srl by Fondazione Enea Tech e Biomedical, JCR Pharmaceuticals Co., Ltd., and Lonza Group Ltd are building advanced manufacturing and commercialization frameworks. Novartis AG integrates cellular therapies within its global pipeline, while NuVasive Inc. and Pluristyx, Inc. deliver specialized instruments and reprogramming reagents. RTI Surgical, Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific Inc. round out the landscape by supplying critical surgical systems, development partnerships, and laboratory services essential for holistic stem cell workflows.

Actionable Recommendations for Industry Leaders

To capitalize on emerging opportunities and navigate evolving challenges, industry leaders should prioritize several strategic actions. First, investing in modular, scalable manufacturing infrastructure that accommodates multiple cell types will reduce production bottlenecks and support rapid pipeline expansion. Second, establishing hybrid supply-chain models that blend domestic and international sourcing will mitigate tariff-driven cost pressures and ensure continuity of critical inputs. Third, engaging proactively with regulatory agencies to pilot novel approval pathways and adaptive protocols will shorten clinical timelines and enhance market access. Fourth, forming consortiums with academic, clinical, and technology partners can accelerate translational research, while co-development agreements unlock shared expertise and risk-sharing benefits. Finally, adopting digital platforms for real-time process monitoring and data analytics will strengthen quality assurance and drive continuous improvement across development stages.

Concluding Perspectives on Strategic Stem Cell Growth

The stem cell sector is poised for sustained growth, fueled by scientific breakthroughs, evolving regulatory frameworks, and expanding clinical validation. By integrating insights from segmentation analyses, regional dynamics, and company strategies, stakeholders can craft robust roadmaps that balance innovation with operational resilience. Embracing collaborative models and technological convergence will enable faster translation of laboratory discoveries into safe, effective therapies. As the landscape matures, organizations that remain agile in the face of policy shifts and supply-chain complexities will emerge as industry frontrunners. Ultimately, a clear strategic vision-underpinned by data-driven decision-making and proactive engagement across the value chain-will be essential for unlocking the full potential of stem cell technologies.

Market Segmentation & Coverage

This research report categorizes the Stem Cells Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Adult Stem Cells
    • Epithelial Stem Cells
    • Hematopoietic Stem Cells
    • Mesenchymal Stem Cells
    • Neural Stem Cells
    • Skin Stem Cells
  • Embryonic Stem Cells
    • Diapause Embryonic Stem Cells
    • Pluripotent Stem Cells
    • Totipotent Stem Cells
  • Induced Pluripotent Stem Cells
    • Differentiation Applications
    • Reprogramming Methods
  • Perinatal Stem Cells
    • Placental Stem Cells
    • Umbilical Cord Blood Stem Cells
  • Cancer Research
    • Stem Cell Therapies in Oncology
    • Tumorigenesis Studies
  • Drug Development
    • Pharmacodynamics
    • Target Identification
    • Toxicology Studies
  • Regenerative Medicine
    • Cell Therapy
    • Organ Transplantation
    • Tissue Engineering
  • Research
    • Cell Biology
    • Developmental Biology
    • Gene Editing
  • Cryopreservation
    • Slow-Freezing Methods
    • Vitrification Techniques
  • Cultivation Techniques
    • Bioreactors
    • Three-Dimensional Cultures
  • Gene Editing
    • CRISPR Technology
    • TALENs
    • Zinc Finger Nucleases
  • Allogeneic Stem Cells
    • Cord Blood
    • Placenta
  • Autologous Stem Cells
    • Bone Marrow
    • Peripheral Blood
  • Academic Institutes
    • Biological Sciences
    • Stem Cell Research Departments
  • Biotechnology Companies
    • Biomanufacturing
    • Therapeutic Development
  • Contract Research Organizations
    • Clinical Trials
    • Preclinical Studies
  • Hospitals & Clinics
    • Stem Cell Therapy Units
    • Transplant Therapies

This research report categorizes the Stem Cells Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Stem Cells Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Advanced Cell Technology, Inc.
  • AlloSource, Inc.
  • Anterogen Co., Ltd.
  • Athersys Inc.
  • Becton, Dickinson and Company
  • Bioheart Inc.
  • Biorestorative Therapies Inc.
  • BioTime, Inc.
  • BrainStorm Cell Therapeutics Inc.
  • Celgene Corporation
  • Cellartis AB
  • CellGenix GmbH
  • Cellular Engineering Technologies Inc.
  • Gamida Cell Ltd
  • GenScript Biotech Corporation
  • Gilead Sciences, Inc.
  • Holostem Terapie Avanzate Srl by Fondazione Enea Tech e Biomedical,
  • JCR Pharmaceuticals Co., Ltd.
  • Lonza Group Ltd
  • Novartis AG
  • NuVasive Inc.
  • Pluristyx, Inc.
  • RTI Surgical
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Stem Cells Market, by Type
8.1. Introduction
8.2. Adult Stem Cells
8.2.1. Epithelial Stem Cells
8.2.2. Hematopoietic Stem Cells
8.2.3. Mesenchymal Stem Cells
8.2.4. Neural Stem Cells
8.2.5. Skin Stem Cells
8.3. Embryonic Stem Cells
8.3.1. Diapause Embryonic Stem Cells
8.3.2. Pluripotent Stem Cells
8.3.3. Totipotent Stem Cells
8.4. Induced Pluripotent Stem Cells
8.4.1. Differentiation Applications
8.4.2. Reprogramming Methods
8.5. Perinatal Stem Cells
8.5.1. Placental Stem Cells
8.5.2. Umbilical Cord Blood Stem Cells
9. Stem Cells Market, by Application
9.1. Introduction
9.2. Cancer Research
9.2.1. Stem Cell Therapies in Oncology
9.2.2. Tumorigenesis Studies
9.3. Drug Development
9.3.1. Pharmacodynamics
9.3.2. Target Identification
9.3.3. Toxicology Studies
9.4. Regenerative Medicine
9.4.1. Cell Therapy
9.4.2. Organ Transplantation
9.4.3. Tissue Engineering
9.5. Research
9.5.1. Cell Biology
9.5.2. Developmental Biology
9.5.3. Gene Editing
10. Stem Cells Market, by Technology
10.1. Introduction
10.2. Cryopreservation
10.2.1. Slow-Freezing Methods
10.2.2. Vitrification Techniques
10.3. Cultivation Techniques
10.3.1. Bioreactors
10.3.2. Three-Dimensional Cultures
10.4. Gene Editing
10.4.1. CRISPR Technology
10.4.2. TALENs
10.4.3. Zinc Finger Nucleases
11. Stem Cells Market, by Source
11.1. Introduction
11.2. Allogeneic Stem Cells
11.2.1. Cord Blood
11.2.2. Placenta
11.3. Autologous Stem Cells
11.3.1. Bone Marrow
11.3.2. Peripheral Blood
12. Stem Cells Market, by End-User
12.1. Introduction
12.2. Academic Institutes
12.2.1. Biological Sciences
12.2.2. Stem Cell Research Departments
12.3. Biotechnology Companies
12.3.1. Biomanufacturing
12.3.2. Therapeutic Development
12.4. Contract Research Organizations
12.4.1. Clinical Trials
12.4.2. Preclinical Studies
12.5. Hospitals & Clinics
12.5.1. Stem Cell Therapy Units
12.5.2. Transplant Therapies
13. Americas Stem Cells Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Stem Cells Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Stem Cells Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Advanced Cell Technology, Inc.
16.3.2. AlloSource, Inc.
16.3.3. Anterogen Co., Ltd.
16.3.4. Athersys Inc.
16.3.5. Becton, Dickinson and Company
16.3.6. Bioheart Inc.
16.3.7. Biorestorative Therapies Inc.
16.3.8. BioTime, Inc.
16.3.9. BrainStorm Cell Therapeutics Inc.
16.3.10. Celgene Corporation
16.3.11. Cellartis AB
16.3.12. CellGenix GmbH
16.3.13. Cellular Engineering Technologies Inc.
16.3.14. Gamida Cell Ltd
16.3.15. GenScript Biotech Corporation
16.3.16. Gilead Sciences, Inc.
16.3.17. Holostem Terapie Avanzate Srl by Fondazione Enea Tech e Biomedical,
16.3.18. JCR Pharmaceuticals Co., Ltd.
16.3.19. Lonza Group Ltd
16.3.20. Novartis AG
16.3.21. NuVasive Inc.
16.3.22. Pluristyx, Inc.
16.3.23. RTI Surgical
16.3.24. Takeda Pharmaceutical Company Limited
16.3.25. Thermo Fisher Scientific Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. STEM CELLS MARKET MULTI-CURRENCY
FIGURE 2. STEM CELLS MARKET MULTI-LANGUAGE
FIGURE 3. STEM CELLS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. STEM CELLS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. STEM CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL STEM CELLS MARKET SIZE, BY EPITHELIAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL STEM CELLS MARKET SIZE, BY NEURAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL STEM CELLS MARKET SIZE, BY SKIN STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL STEM CELLS MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL STEM CELLS MARKET SIZE, BY DIAPAUSE EMBRYONIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL STEM CELLS MARKET SIZE, BY PLURIPOTENT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL STEM CELLS MARKET SIZE, BY TOTIPOTENT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL STEM CELLS MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL STEM CELLS MARKET SIZE, BY DIFFERENTIATION APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL STEM CELLS MARKET SIZE, BY REPROGRAMMING METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL STEM CELLS MARKET SIZE, BY PERINATAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL STEM CELLS MARKET SIZE, BY PLACENTAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL STEM CELLS MARKET SIZE, BY UMBILICAL CORD BLOOD STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL STEM CELLS MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL STEM CELLS MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL STEM CELLS MARKET SIZE, BY STEM CELL THERAPIES IN ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL STEM CELLS MARKET SIZE, BY TUMORIGENESIS STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL STEM CELLS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL STEM CELLS MARKET SIZE, BY PHARMACODYNAMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL STEM CELLS MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL STEM CELLS MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL STEM CELLS MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL STEM CELLS MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL STEM CELLS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL STEM CELLS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL STEM CELLS MARKET SIZE, BY CELL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL STEM CELLS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL STEM CELLS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL STEM CELLS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL STEM CELLS MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL STEM CELLS MARKET SIZE, BY SLOW-FREEZING METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL STEM CELLS MARKET SIZE, BY VITRIFICATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL STEM CELLS MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL STEM CELLS MARKET SIZE, BY CULTIVATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL STEM CELLS MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL STEM CELLS MARKET SIZE, BY CULTIVATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL STEM CELLS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL STEM CELLS MARKET SIZE, BY CRISPR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL STEM CELLS MARKET SIZE, BY TALENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL STEM CELLS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL STEM CELLS MARKET SIZE, BY CORD BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL STEM CELLS MARKET SIZE, BY PLACENTA, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS STEM CELLS, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL STEM CELLS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL STEM CELLS MARKET SIZE, BY BIOLOGICAL SCIENCES, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL STEM CELLS MARKET SIZE, BY STEM CELL RESEARCH DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL STEM CELLS MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL STEM CELLS MARKET SIZE, BY BIOMANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL STEM CELLS MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL STEM CELLS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL STEM CELLS MARKET SIZE, BY PRECLINICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL STEM CELLS MARKET SIZE, BY STEM CELL THERAPY UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL STEM CELLS MARKET SIZE, BY TRANSPLANT THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS STEM CELLS MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS STEM CELLS MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS STEM CELLS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS STEM CELLS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS STEM CELLS MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS STEM CELLS MARKET SIZE, BY CULTIVATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS STEM CELLS MARKET SIZE, BY AUTOLOGOUS STEM CELLS, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS STEM CELLS MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA STEM CELLS MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA STEM CELLS MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA STEM CELLS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA STEM CELLS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA STEM CELLS MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA STEM CELLS MARKET SIZE, BY CULTIVATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA STEM CELLS MARKET SIZE, BY AUTOLOGOUS STEM CELLS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA STEM CELLS MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL STEM CELLS MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL STEM CELLS MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL STEM CELLS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL STEM CELLS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL STEM CELLS MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL STEM CELLS MARKET SIZE, BY CULTIVATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL STEM CELLS MARKET SIZE, BY AUTOLOGOUS STEM CELLS, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL STEM CELLS MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 154. CANADA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. CANADA STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 156. CANADA STEM CELLS MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 157. CANADA STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 158. CANADA STEM CELLS MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 159. CANADA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. CANADA STEM CELLS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 161. CANADA STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 162. CANADA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 163. CANADA STEM CELLS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 164. CANADA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. CANADA STEM CELLS MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 166. CANADA STEM CELLS MARKET SIZE, BY CULTIVATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 167. CANADA STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 168. CANADA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 169. CANADA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 170. CANADA STEM CELLS MARKET SIZE, BY AUTOLOGOUS STEM CELLS, 2018-2030 (USD MILLION)
TABLE 171. CANADA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. CANADA STEM CELLS MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 173. CANADA STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 174. CANADA STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 175. CANADA STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 176. MEXICO STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. MEXICO STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 178. MEXICO STEM CELLS MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 179. MEXICO STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 180. MEXICO STEM CELLS MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 181. MEXICO STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. MEXICO STEM CELLS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 183. MEXICO STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 184. MEXICO STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 185. MEXICO STEM CELLS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 186. MEXICO STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. MEXICO STEM CELLS MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 188. MEXICO STEM CELLS MARKET SIZE, BY CULTIVATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 189. MEXICO STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 190. MEXICO STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 191. MEXICO STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 192. MEXICO STEM CELLS MARKET SIZE, BY AUTOLOGOUS STEM CELLS, 2018-2030 (USD MILLION)
TABLE 193. MEXICO STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. MEXICO STEM CELLS MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 195. MEXICO STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 196. MEXICO STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 197. MEXICO STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES STEM CELLS MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES STEM CELLS MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES STEM CELLS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES STEM CELLS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. UNITED STATES STEM CELLS MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 210. UNITED STATES STEM CELLS MARKET SIZE, BY CULTIVATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES STEM CELLS MARKET SIZE, BY AUTOLOGOUS STEM CELLS, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES STEM CELLS MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY CULTIVATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY AUTOLOGOUS STEM CELLS, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA STEM CELLS MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA STEM CELLS MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA STEM CELLS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 251. AUSTRALIA STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA STEM CELLS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 254. AUSTRALIA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 255. AUSTRALIA STEM CELLS MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 256. AUSTRALIA STEM CELLS MARKET SIZE, BY CULTIVATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 257. AUSTRALIA STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS STEM CELLS, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA STEM CELLS MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 266. CHINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 267. CHINA STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 268. CHINA STEM CELLS MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 269. CHINA STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 270. CHINA STEM CELLS MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 271. CHINA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. CHINA STEM CELLS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 273. CHINA STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 274. CHINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 275. CHINA STEM CELLS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 276. CHINA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. CHINA STEM CELLS MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 278. CHINA STEM CELLS MARKET SIZE, BY CULTIVATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 279. CHINA STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 280. CHINA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 281. CHINA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 282. CHINA STEM CELLS MARKET SIZE, BY AUTOLOGOUS STEM CELLS, 2018-2030 (USD MILLION)
TABLE 283. CHINA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. CHINA STEM CELLS MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 285. CHINA STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 286. CHINA STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 287. CHINA STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 288. INDIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 289. INDIA STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 290. INDIA STEM CELLS MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 291. INDIA STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 292. INDIA STEM CELLS MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 293. INDIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. INDIA STEM CELLS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 295. INDIA STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 296. INDIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 297. INDIA STEM CELLS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 298. INDIA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 299. INDIA STEM CELLS MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 300. INDIA STEM CELLS MARKET SIZE, BY CULTIVATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 301. INDIA STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 302. INDIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 303. INDIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 304. INDIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS STEM CELLS, 2018-2030 (USD MILLION)
TABLE 305. INDIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 306. INDIA STEM CELLS MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 307. INDIA STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 308. INDIA STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 309. INDIA STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 310. INDONESIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA STEM CELLS MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA STEM CELLS MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA STEM CELLS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA STEM CELLS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA STEM CELLS MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA STEM CELLS MARKET SIZE, BY CULTIVATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 323. INDONESIA STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 324. INDONESIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 325. INDONESIA STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 326. INDONESIA STEM CELLS MARKET SIZE, BY AUTOLOGOUS STEM CELLS, 2018-2030 (USD MILLION)
TABLE 327. INDONESIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 328. INDONESIA STEM CELLS MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 329. INDONESIA STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 330. INDONESIA STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 331. INDONESIA STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 332. JAPAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 333. JAPAN STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 334. JAPAN STEM CELLS MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 335. JAPAN STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 336. JAPAN STEM CELLS MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 337. JAPAN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. JAPAN STEM CELLS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 339. JAPAN STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 340. JAPAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 341. JAPAN STEM CELLS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 342. JAPAN STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 343. JAPAN STEM CELLS MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 344. JAPAN STEM CELLS MARKET SIZE, BY CULTIVATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 345. JAPAN STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 346. JAPAN STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 347. JAPAN STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 348. JAPAN STEM CELLS MARKET SIZE, BY AUTOLOGOUS STEM CELLS, 2018-2030 (USD MILLION)
TABLE 349. JAPAN STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 350. JAPAN STEM CELLS MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 351. JAPAN STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 352. JAPAN STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 353. JAPAN STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 354. MALAYSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 355. MALAYSIA STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 356. MALAYSIA STEM CELLS MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 357. MALAYSIA STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 358. MALAYSIA STEM CELLS MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 359. MALAYSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 360. MALAYSIA STEM CELLS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 361. MALAYSIA STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 362. MALAYSIA STEM CELLS MARKE

Companies Mentioned

  • Advanced Cell Technology, Inc.
  • AlloSource, Inc.
  • Anterogen Co., Ltd.
  • Athersys Inc.
  • Becton, Dickinson and Company
  • Bioheart Inc.
  • Biorestorative Therapies Inc.
  • BioTime, Inc.
  • BrainStorm Cell Therapeutics Inc.
  • Celgene Corporation
  • Cellartis AB
  • CellGenix GmbH
  • Cellular Engineering Technologies Inc.
  • Gamida Cell Ltd
  • GenScript Biotech Corporation
  • Gilead Sciences, Inc.
  • Holostem Terapie Avanzate Srl by Fondazione Enea Tech e Biomedical,
  • JCR Pharmaceuticals Co., Ltd.
  • Lonza Group Ltd
  • Novartis AG
  • NuVasive Inc.
  • Pluristyx, Inc.
  • RTI Surgical
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Stem Cell Therapy Market - Global Forecast to 2030 - Product Image

Stem Cell Therapy Market - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Stem Cells Market Size, Share & Trends Analysis Report by Product (Adult Stem Cells, Human Embryonic Stem Cells), Application (Regenerative Medicine), Technology, Therapy, End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Stem Cells Market Size, Share & Trends Analysis Report by Product (Adult Stem Cells, Human Embryonic Stem Cells), Application (Regenerative Medicine), Technology, Therapy, End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Stem Cell Banking Market - Global Forecast to 2030 - Product Image

Stem Cell Banking Market - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Human Embryonic Stem Cells Market Size, Share & Trends Analysis Report By Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Human Embryonic Stem Cells Market Size, Share & Trends Analysis Report By Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Stem Cell - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Stem Cell - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From

About the Stem Cells Market

The Stem Cells market is a rapidly growing industry that focuses on the use of stem cells for medical treatments and research. Stem cells are cells that have the potential to develop into many different types of cells in the body. They can be used to replace or repair damaged tissue, and can be used to treat a variety of diseases and conditions. Stem cell research has been ongoing for decades, and the potential for medical treatments is vast. Companies in the Stem Cells market are focused on developing treatments and therapies that use stem cells to treat a variety of diseases and conditions. These companies are also researching ways to use stem cells to create new organs and tissues for transplantation. Some of the major companies in the Stem Cells market include Celgene, Novartis, and Regeneron. These companies are focused on developing treatments and therapies that use stem cells to treat a variety of diseases and conditions. Other companies in the market include BioTime, Osiris Therapeutics, and Vericel Corporation. These companies are focused on developing treatments and therapies that use stem cells to treat a variety of diseases and conditions. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.